Search

Search Constraints

You searched for: Author/Creator Chen, Fangjun

Search Results

2. Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer (Adv. Sci. 1/2023). Issue 1 (4th January 2023)

3. Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer. Issue 1 (9th November 2022)

5. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. (2nd January 2017)